دورية أكاديمية

Routine mechanical ventricular assist following the Norwood procedure—improved neurologic outcome and excellent hospital survival.

التفاصيل البيبلوغرافية
العنوان: Routine mechanical ventricular assist following the Norwood procedure—improved neurologic outcome and excellent hospital survival.
المؤلفون: Ungerleider, Ross M., Shen, Irving, Yeh Jr, Thomas, Schultz, Jess, Butler, Robert, Silberbach, Michael, Giacomuzzi, Carmen, Heller, Eileen, Studenberg, Leanne, Mejak, Brian, You, Jamie, Farrel, Debbie, McClure, Scott, Austin, Erle H.
المصدر: Annals of Thoracic Surgery; Jan2004, Vol. 77 Issue 1, p18, 5p
مصطلحات موضوعية: HEART diseases, CARDIOPULMONARY bypass, CARDIOLOGY, SURGERY
مستخلص: : BackgroundAlthough excellent survival following the Norwood procedure for palliation of hypoplastic left heart syndrome (HLHS) is being achieved by some, most centers, especially the ones with small surgical volume and limited experience, continue to struggle with initial results. Survivors often showed evidence of significant neurologic injury. The early postoperative care is labor-intensive as attempts are made to balance the systemic and pulmonary circulation for these infants. We report our experience with routine use of mechanical circulatory assist to support the increased cardiac output requirements present following Norwood procedure.: MethodsEighteen consecutive infants undergoing Norwood operation for HLHS (Oregon Health & Science University [OHSU] 13; University of Louisville [UL] 5) were placed on a ventricular assist device (VAD) immediately following modified ultrafiltration in the operating room using the cardiopulmonary bypass (CPB) cannulas that were in the right atrium and the neoaorta. VAD flows were maintained at approximately 200 mL · kg−1 · min−1 and the patients were transported to the intensive care unit (ICU). Patients operated at OHSU also received neurodevelopmental testing before their Glenn procedure, approximately 4 to 6 months following their Norwood operation.: ResultsAll patients were stable on VAD support and no attempt was made to balance the systemic and pulmonary circulation. The ventilator was manipulated to achieve systemic Pa02 between 30 and 45 mm Hg and PaC02 between 35 and 45 mm Hg. Evidence of hypoperfusion (increasing lactates) was managed by increasing the VAD flow. Lactates normalized [< 2 mmol/L]) by 1.8 ± 1.1 days following surgery. Average time of VAD support was 3.1 ± 1.0 (range, 2 to 5 days) and average time until chest closure was 3.4 ± 1.5 (range, 2 to 8 days). There were two cases of postoperative bleeding (11.1%) requiring reexploration and one case of mediastinitis (5.5%) in a patient who has now gone on to successful Glenn. Sixteen of the eighteen patients survived (hospital survival mean 89% with a 95% confidence interval of 63.9% to 98.1%; 12/13 OHSU [92.3%]; 4/5 UL [80%]). Neurodevelopmental testing using the Mullen Scales of Early Learning and the Vineland Adaptive Behavior Scale were normal for all infants tested.: ConclusionsRoutine postoperative use of VAD can support the increased cardiac output demands of infants following Norwood operation and results in a stable postoperative convalescence that does not require aggressive ventilator or inotrope manipulation. Although not a panacea, this strategy can simplify postoperative management, lead to excellent hospital survival, and possibly augment cerebral oxygen delivery, resulting in improved neurologic outcomes for this challenging group of patients. [Copyright &y& Elsevier]
Copyright of Annals of Thoracic Surgery is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:00034975
DOI:10.1016/S0003-4975(03)01365-1